verapamil has been researched along with Pituitary Neoplasms in 22 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil stimulation test was previously investigated as a tool for differential diagnosis of hyperprolactinemia, but with conflicting results." | 7.76 | Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect. ( Dagdelen, S; Usman, A, 2010) |
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 7.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "Verapamil stimulation test was previously investigated as a tool for differential diagnosis of hyperprolactinemia, but with conflicting results." | 3.76 | Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect. ( Dagdelen, S; Usman, A, 2010) |
| "To describe a patient with an incidental pituitary lesion who experienced verapamil-induced hyperprolactinemia." | 3.69 | Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma. ( Aron, DC; Dombrowski, RC; Romeo, JH, 1995) |
| "Cluster headache is classified as a primary headache by definition not caused by an underlying pathology." | 1.43 | Chronic cluster headache and the pituitary gland. ( De Pue, A; Lutin, B; Paemeleire, K, 2016) |
| "Magnetic resonance imaging showed a pituitary adenoma which invaded into right cavernous sinus." | 1.33 | [Cluster like headache in a patient with the Maffucci's syndrome]. ( Imai, N; Kitamura, E; Konisi, T; Okabe, T; Serizawa, M; Suzuki, Y, 2006) |
| "Serum from patients with IDDM increased L-type calcium channel activity of insulin-producing cells and of GH3 cells derived from a pituitary tumor." | 1.29 | Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes. ( Ammälä, C; Bokvist, K; Dypbukt, J; Hallberg, A; Juntti-Berggren, L; Larsson, O; Nicotera, P; Orrenius, S; Rorsman, P; Wåhlander, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (59.09) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 2 (9.09) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Pue, A | 1 |
| Lutin, B | 1 |
| Paemeleire, K | 1 |
| Dagdelen, S | 1 |
| Usman, A | 1 |
| Kitamura, E | 1 |
| Imai, N | 1 |
| Konisi, T | 1 |
| Suzuki, Y | 1 |
| Serizawa, M | 1 |
| Okabe, T | 1 |
| Kozminski, M | 1 |
| Gershengorn, MC | 3 |
| Ozawa, S | 1 |
| Kimura, N | 1 |
| Albert, PR | 1 |
| Tashjian, AH | 2 |
| Geras, E | 1 |
| Rebecchi, MJ | 1 |
| Juntti-Berggren, L | 1 |
| Larsson, O | 1 |
| Rorsman, P | 1 |
| Ammälä, C | 1 |
| Bokvist, K | 1 |
| Wåhlander, K | 1 |
| Nicotera, P | 1 |
| Dypbukt, J | 1 |
| Orrenius, S | 1 |
| Hallberg, A | 1 |
| Jancis, EM | 1 |
| Carbone, R | 1 |
| Loechner, KJ | 1 |
| Dannies, PS | 1 |
| Dombrowski, RC | 1 |
| Romeo, JH | 1 |
| Aron, DC | 1 |
| Yang, JP | 1 |
| Sato, N | 1 |
| Wang, XB | 1 |
| Greer, MA | 1 |
| Greer, SE | 1 |
| McAdams, S | 1 |
| Oshima, T | 1 |
| Richardson, UI | 1 |
| Heisler, S | 1 |
| Sletholt, K | 1 |
| Haug, E | 1 |
| Gautvik, KM | 1 |
| Schettini, G | 1 |
| Meucci, O | 1 |
| Florio, T | 1 |
| Grimaldi, M | 1 |
| Landolfi, E | 1 |
| Magri, G | 1 |
| Yasumoto, T | 1 |
| Davis, JR | 1 |
| Vidal, ME | 1 |
| Wilson, EM | 1 |
| Sheppard, MC | 1 |
| Wolfe, SE | 1 |
| Brostrom, CO | 1 |
| Brostrom, MA | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Minnielli, S | 1 |
| D'Amico, C | 1 |
| Di Pietro, ML | 1 |
| Albini, C | 1 |
| Passeri, M | 1 |
| Liberale, I | 1 |
| Menini, E | 1 |
| Barbarino, A | 1 |
| Thaw, C | 1 |
| Enyeart, JJ | 1 |
| Aizawa, T | 1 |
| Hinkle, PM | 1 |
1 review available for verapamil and Pituitary Neoplasms
| Article | Year |
|---|---|
Thyrotropin releasing hormone. A review of the mechanisms of acute stimulation of pituitary hormone release.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Cells, Cultured; Chlortetracycline; Cyclic AMP; Guany | 1982 |
21 other studies available for verapamil and Pituitary Neoplasms
| Article | Year |
|---|---|
Chronic cluster headache and the pituitary gland.
Topics: Adenoma; Cabergoline; Central Nervous System Cysts; Cluster Headache; Diagnosis, Differential; Dopam | 2016 |
Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
Topics: Adult; Biomarkers; Case-Control Studies; Diagnosis, Differential; Female; Humans; Hyperprolactinemia | 2010 |
[Cluster like headache in a patient with the Maffucci's syndrome].
Topics: Adenoma; Cluster Headache; Enchondromatosis; Humans; Magnetic Resonance Imaging; Male; Middle Aged; | 2006 |
Resident and fellow section. Expert opinion: trigeminal autonomic cephalgia post transsphenoidal surgery.
Topics: Adenoma; Adrenal Insufficiency; Adult; Analgesics; Anticonvulsants; Carbamazepine; Diabetes Insipidu | 2008 |
Calcium channel and prolactin release in rat clonal pituitary cells: effects of verapamil.
Topics: Action Potentials; Animals; Calcium; Cell Line; Ion Channels; Kinetics; Pituitary Neoplasms; Prolact | 1982 |
Relationship of thyrotropin-releasing hormone-induced spike and plateau phases in cytosolic free Ca2+ concentrations to hormone secretion. Selective blockade using ionomycin and nifedipine.
Topics: Animals; Calcium; Cell Line; Cytosol; Ethers; Growth Hormone; Ionomycin; Kinetics; Nifedipine; Pitui | 1984 |
Evidence that stimulation of thyrotropin and prolactin secretion by thyrotropin-releasing hormone occur via different calcium-mediated mechanisms: studies with verapamil.
Topics: Animals; Biological Transport, Active; Calcium; Kinetics; Mice; Neoplasms, Experimental; Pituitary N | 1982 |
Increased activity of L-type Ca2+ channels exposed to serum from patients with type I diabetes.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells.
Topics: Animals; Cyclosporins; Drug Resistance; Estradiol; Pituitary Neoplasms; Rats; Rhodamine 123; Rhodami | 1993 |
Verapamil-induced hyperprolactinemia complicated by a pituitary incidentaloma.
Topics: Aged; Calcium Channel Blockers; Erectile Dysfunction; Humans; Hyperprolactinemia; Magnetic Resonance | 1995 |
Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells.
Topics: Animals; Calcium; Calcium Channels; Cell Line; Diterpenes; Dose-Response Relationship, Drug; Egtazic | 1991 |
Medium hyposmolarity stimulates prolactin secretion in GH4C1 cells by inducing an increase in cytosolic free calcium.
Topics: Animals; Calcium; Cell Line; Culture Media; Cytosol; Hypotonic Solutions; Kinetics; Nifedipine; Pitu | 1990 |
Multiple classes of calcium channels in mouse pituitary tumor cells.
Topics: Adrenocorticotropic Hormone; Animals; Calcium; Cell Membrane; Clone Cells; Cobalt; Corticotropin-Rel | 1986 |
BAY-K-8644-stimulated cyclic GMP synthesis in mouse pituitary tumor cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1986 |
On the involvement of cyclic AMP and extracellular Ca2+ in the regulation of hormone release from rat pituitary tumour (GH3) cells in culture.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Calcimycin; Calcium; Cell Line; Cobalt; Cyclic AM | 1987 |
Pertussis toxin pretreatment abolishes dihydropyridine inhibition of calcium flux in the 235-1 pituitary cell line.
Topics: Animals; Calcium; Dihydropyridines; Ion Channels; Marine Toxins; Nicardipine; Oxocins; Pertussis Tox | 1988 |
Calcium dependence of prolactin mRNA accumulation in GH3 rat pituitary tumour cells.
Topics: Calcium; Cell Line; Cobalt; Hybridization, Genetic; Immunoblotting; Pituitary Neoplasms; Prolactin; | 1988 |
Mechanisms of action of inhibitors of prolactin secretion in GH3 pituitary cells. I. Ca2+-dependent inhibition of amino acid incorporation.
Topics: Acetylcholine; Amino Acids; Animals; Bromocriptine; Calcium; Carbachol; Cell Line; Chlorpromazine; I | 1986 |
Calcium antagonists and hormone release. V. Effects of a calcium-antagonist (verapamil) on pituitary hormone release in hypersecretory states.
Topics: Acromegaly; Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypogonadism; Hypothyroidism; Male; | 1987 |
Thyrotropin-releasing hormone (TRH) stimulates biphasic elevation of cytoplasmic free calcium in GH3 cells. Further evidence that TRH mobilizes cellular and extracellular Ca2+.
Topics: Aminoquinolines; Animals; Calcium; Cell Line; Cytoplasm; Extracellular Space; Fluorescent Dyes; Nife | 1985 |
Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
Topics: Animals; Calcium Channel Blockers; Cell Line; Growth Hormone; Nicotinic Acids; Nifedipine; Nimodipin | 1985 |